Efficacy and Safety Evaluation of Sintilimab or Placebo in Combination With XELOX as First Line Treatment in Patients With Gastric Cancer

NCT03745170 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

650

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Sintilimab
DRUG: Oxaliplatin
DRUG: Capecitabine
DRUG: placebo

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.